Signal Transduction in Receptor for Advanced Glycation End Products (RAGE): SOLUTION STRUCTURE OF C-TERMINAL RAGE (ctRAGE) AND ITS BINDING TO mDia1
about
Structural insights into the oligomerization mode of the human receptor for advanced glycation end-productsThe effect of soluble RAGE on inhibition of angiotensin II-mediated atherosclerosis in apolipoprotein E deficient miceThe multiple faces of RAGE--opportunities for therapeutic intervention in aging and chronic diseaseIschemia-reperfusion injury of the retina is linked to necroptosis via the ERK1/2-RIP3 pathway.Oligomerization interface of RAGE receptor revealed by MS-monitored hydrogen deuterium exchangeAlternative splicing of the RAGE cytoplasmic domain regulates cell signaling and function.Modeling the interaction between quinolinate and the receptor for advanced glycation end products (RAGE): relevance for early neuropathological processesStructural insights into the binding of the human receptor for advanced glycation end products (RAGE) by S100B, as revealed by an S100B-RAGE-derived peptide complex.Adaptive evolution of the MHC class III-encoded receptor RAGE in primates and murine rodents.Small Molecule Inhibition of Ligand-Stimulated RAGE-DIAPH1 Signal TransductionFormin mDia1 mediates vascular remodeling via integration of oxidative and signal transduction pathways.Emerging Targets for Therapeutic Development in Diabetes and Its Complications: The RAGE Signaling Pathway.The novel RAGE interactor PRAK is associated with autophagy signaling in Alzheimer's disease pathogenesisHeparanase induced by advanced glycation end products (AGEs) promotes macrophage migration involving RAGE and PI3K/AKT pathwayThe HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics.The diverse ligand repertoire of the receptor for advanced glycation endproducts and pathways to the complications of diabetes.RAGE regulation and signaling in inflammation and beyond.Unlocking the biology of RAGE in diabetic microvascular complicationsTargeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective.2016 ATVB Plenary Lecture: Receptor for Advanced Glycation Endproducts and Implications for the Pathogenesis an Treatment of Cardiometabolic Disorders: Spotlight on the Macrophage.Cellular mechanisms and consequences of glycation in atherosclerosis and obesity.Glycation & the RAGE axis: targeting signal transduction through DIAPH1.RAGE-TLR Crosstalk Sustains Chronic Inflammation in Neurodegeneration.Change in the Molecular Dimension of a RAGE-Ligand Complex Triggers RAGE Signaling.Identifying key juxtamembrane interactions in cell membranes using AraC-based transcriptional reporter assay (AraTM).Increased expression of the receptor for advanced glycation end-products in human peripheral neuropathies.NMR characterization of the C-terminal tail of full-length RAGE in a membrane mimicking environment.Impaired slow axonal transport in diabetic peripheral nerve is independent of RAGE.The AGE-RAGE Axis: Implications for Age-Associated Arterial Diseases.The Receptor for Advanced Glycation Endproducts is a mediator of toxicity by IAPP and other proteotoxic aggregates: Establishing and Exploiting Common Ground for Novel Amyloidosis Therapies.Biomarkers in Idiopathic Pulmonary Fibrosis: A RAGE-ing Bull in the Arena.
P2860
Q24338271-25B77B15-0D2A-4C69-A43A-3952D6F6EBB8Q28535046-3921FAA1-29E8-4F4E-9008-8C482A315826Q28830568-5A706F00-9746-45CF-A2EB-9ED16A533471Q34229514-1BF2AE52-2B54-4626-B527-F91935DE6957Q35009387-678DA3B7-1BD7-45D9-8DE3-E3ED466F4E7BQ35048039-BFD8FB4A-367B-4CC6-AB09-57F92B49F711Q35163077-E0C3F20E-CD49-48CE-AFBC-0C2000368BE8Q35592681-1CB42698-BDF8-4110-924C-5F0D5E65E54DQ35780980-CA7F38BC-9789-453E-BD40-CAF186014A7FQ35943768-68DA1DA6-8EE8-4BC7-ABC9-B8ABCC2ECDF7Q36054820-17E6C156-CEA7-427F-B27E-08342F6E9617Q36207823-BD5CCD18-5390-40A7-A98C-EFCCEADA780FQ36454454-3A4BD575-1573-4FAE-84E8-AF44B3940F0DQ36797594-316ECC10-1BA1-41B6-B017-F8800EE8C6EFQ37227378-FD747E90-B88F-45D3-8A54-A0F282CA4D69Q38023062-A587A8E1-251E-4D26-A67F-E9A56AFB50E1Q38094691-36B91DAE-AED4-4D1B-A546-D151AA38FEC6Q38134924-AD659628-6188-4198-846C-2CE4D13F29ABQ38686477-B09E2ACC-3BCF-48B3-B8DE-E298E93A1395Q38759194-9D609C4B-7E20-4544-A9B8-41862ABD2C9EQ38831558-E96E7D8E-FEEE-4767-97EB-D350DF121D75Q39038218-7ABEB76E-7093-40E4-B5C9-23814F1B79E2Q39123617-1EF441A3-8A06-4C2E-B9C2-C058EB1B6A12Q41036883-AB24CBC1-C8C6-488F-A3F5-94348E722853Q41957636-5DD801D8-E8C5-4F55-BF67-B069BCCE3942Q42235792-467053D2-6292-4D6F-9521-DD6C3196653EQ44570526-D06A92BB-6EEE-4042-817B-3977E040C216Q45893258-3B20065B-2AA8-4846-9ACF-6EEC4048193AQ47094524-D45DA1A9-EBA9-47D5-8502-A6576D8BCCE0Q52583445-5F39DCEF-A87A-4DB5-AAAC-BD6DBCB1EA84Q53321598-F899EE2C-45C2-444B-A687-5BC7A3E6E1C1
P2860
Signal Transduction in Receptor for Advanced Glycation End Products (RAGE): SOLUTION STRUCTURE OF C-TERMINAL RAGE (ctRAGE) AND ITS BINDING TO mDia1
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Signal Transduction in Recepto ...... RAGE) AND ITS BINDING TO mDia1
@ast
Signal Transduction in Recepto ...... RAGE) AND ITS BINDING TO mDia1
@en
Signal Transduction in Recepto ...... RAGE) AND ITS BINDING TO mDia1
@nl
type
label
Signal Transduction in Recepto ...... RAGE) AND ITS BINDING TO mDia1
@ast
Signal Transduction in Recepto ...... RAGE) AND ITS BINDING TO mDia1
@en
Signal Transduction in Recepto ...... RAGE) AND ITS BINDING TO mDia1
@nl
prefLabel
Signal Transduction in Recepto ...... RAGE) AND ITS BINDING TO mDia1
@ast
Signal Transduction in Recepto ...... RAGE) AND ITS BINDING TO mDia1
@en
Signal Transduction in Recepto ...... RAGE) AND ITS BINDING TO mDia1
@nl
P2093
P2860
P356
P1476
Signal Transduction in Recepto ...... RAGE) AND ITS BINDING TO mDia1
@en
P2093
Alexander Shekhtman
Andres Y Maldonado
Ann Marie Schmidt
David S Burz
Sergey Reverdatto
Shi Fang Yan
P2860
P304
P356
10.1074/JBC.M111.277731
P407
P577
2012-02-10T00:00:00Z